Safety and Effectiveness of Apixaban Versus Rivaroxaban in Atrial Fibrillation Patients in Singapore: An Active‐Comparator, New‐User Cohort study

Documenti analoghi

• Validation of a Major and Clinically Relevant Nonmajor Bleeding Phenotyping Algorithm on Electronic Health Records
  di: Aaron Jun Yi Yap, et al.
  Pubblicazione: (2024)
• Association Between Statins Use and Major Bleeding in Patients Using Direct Oral Anticoagulants for Atrial Fibrillation
  di: A. de Burgos‐González, et al.
  Pubblicazione: (2025)
• Incidence and Clinical Significance of Drug‐Induced Antibodies and Hemolytic Anemia Associated With Beta‐Lactam Antibiotics: A Prospective Cohort Study
  di: Li Wang, et al.
  Pubblicazione: (2026)
• Clarithromycin Versus Azithromycin for Community‐Acquired Pneumonia and the Risk of Major Adverse Cardiovascular Events: A Multicentre Cohort Study Using Data From Canada and Denmark
  di: Theis Skovsgaard Itenov, et al.
  Pubblicazione: (2025)
• Applying High‐Dimensional Propensity Scores in a Study of Inhaled Corticosteroids and COVID ‐19 Outcomes
  di: Marleen Bokern, et al.
  Pubblicazione: (2025)